Currently predicting for Mon, 1 Apr 2024

Trading levels for CYCC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.22 5.36 %
R2 2.17 2.83 %
R1 2.14 1.27 %
Current price: 2.11
Support S1 2.03 -3.79 %
S2 2.00 -5.36 %
S3 1.94 -7.89 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.49 18.02 %
R2 2.36 11.85 %
R1 2.28 8.06 %
Current price 2.11
Support S1 2.09 -0.94%
S2 2.07 -1.89%
S3 1.92 -9.00%

CYCC Predictions History

2 months ago
JS predicted that CYCC for Jan. 12th is going $2.67 (13.14%)

2 months ago
PredictionBot.Warren predicted that CYCC for Jan. 12th is going $2.66 (12.92%)

2 months ago
PredictionBot.Kathy predicted that CYCC for Jan. 12th is going $2.96 (25.61%)

2 months ago
JS predicted that CYCC for Jan. 9th is going $3.26 (-2.10%)

2 months ago
PredictionBot.Kathy predicted that CYCC for Jan. 9th is going $3.01 (-9.58%)

2 months ago
PredictionBot.Warren predicted that CYCC for Jan. 9th is going $3.08 (-7.56%)

1 year ago
allenperu2k.332421 predicted that CYCC for 2022-07-08 is going

Rank:

3 years ago
JS predicted that CYCC for 2021-03-23 is going $8.12 (5.05%)

3 years ago
sander7100 yo bro predicted that CYCC for 2020-07-22 is going $4.20 (-10.38%)

3 years ago
JS predicted that CYCC for 2020-07-22 is going $4.95 (5.62%)

Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT